Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

Genesis has gained US Food and Drug Administration (FDA) clearance on an Investigational New Drug (IND) application for a ...

Ghosh is at the helm of the HUMANOID™ Center for Excellence at the University of California San Diego, which is pioneering ...

Recce Pharmaceuticals receives Human Research Ethics Committee approval to expand its phase II clinical trial following ...

The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.

REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule MEK 1/2 inhibitor. The platform analyzed cellular models of APC gene loss-the root cause of FAP-to identify compounds ...

Visit https://www.apbioinc.com/en/ for more information about AP Biosciences and its pipeline of next-generation cancer therapies.

Of those, Phase III submissions were the most common ... The MHRA said the data will be used to build on the strengths of the ...

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been ...